AWAK Attracts Investment Billions
Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!
Read the full article » | Posted 06/12/2017
- When Pigs Fly… Posted 09/15/2017
- Home Dialyzors United Helps Guide the Kidney Project Posted 09/15/2017
- DIY Dialysis? Posted 08/17/2017
- VasQ and A Posted 08/17/2017
- Transitioning Home Posted 07/14/2017